Stockscreener 앱 받기
25.36
2.68%
-0.915
전일 마감가:
$26.28
열려 있는:
$26.21
하루 거래량:
433.76K
Relative Volume:
0.17
시가총액:
$3.17B
수익:
-
순이익/손실:
$-238.77M
주가수익비율:
-0.9462
EPS:
-26.808
순현금흐름:
$-216.62M
1주 성능:
+7.19%
1개월 성능:
+123.36%
6개월 성능:
+566.02%
1년 성능:
+289.27%
1일 변동 폭
$25.38
$26.27
1주일 범위
$23.18
$27.20
52주 변동 폭
$2.7601
$27.20
Alumis Inc Stock (ALMS) Company Profile
명칭
Alumis Inc
전화
650-231-6625
주소
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
ALMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALMS
Alumis Inc
|
25.41 | 3.28B | 0 | -238.77M | -216.62M | -26.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.81 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.12 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
830.70 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.33 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
342.01 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-21 | 개시 | Chardan Capital Markets | Buy |
| 2025-07-25 | 개시 | Wells Fargo | Overweight |
| 2025-06-10 | 재개 | Guggenheim | Buy |
| 2025-01-30 | 개시 | Oppenheimer | Outperform |
| 2024-10-31 | 개시 | Robert W. Baird | Outperform |
| 2024-10-17 | 개시 | H.C. Wainwright | Buy |
| 2024-07-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-23 | 개시 | Guggenheim | Buy |
| 2024-07-23 | 개시 | Leerink Partners | Outperform |
| 2024-07-23 | 개시 | Morgan Stanley | Overweight |
모두보기
Alumis Inc 주식(ALMS)의 최신 뉴스
Alumis (NASDAQ:ALMS) Coverage Initiated by Analysts at Chardan Capital - MarketBeat
This Crescent Biopharma Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Chardan Capital initiates coverage on Alumis stock with Buy rating By Investing.com - Investing.com Nigeria
Chardan Capital initiates coverage on Alumis stock with Buy rating - Investing.com
Alumis (NASDAQ:ALMS) Hits New 12-Month HighWhat's Next? - MarketBeat
Profit Recap: Is now the right time to enter ASTCJuly 2025 WrapUp & Technical Confirmation Alerts - baoquankhu1.vn
Trading Recap: Is Alumis Inc gaining market shareJuly 2025 Market Mood & Growth Focused Entry Point Reports - baoquankhu1.vn
Aug Reactions: What is the long term forecast for XPLR Infrastructure LP Limited Partnership stock - baoquankhu1.vn
Alumis stock reaches all-time high at 25.25 USD By Investing.com - Investing.com India
Top Small Cap Stocks To Watch NowJanuary 6th - MarketBeat
Alumis stock reaches all-time high at 25.25 USD - Investing.com
Aug Weekly: What’s Enterprise Products Partners L.P. Limited Partnership’s historical returnMarket Activity Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib - AOL.com
Huge Insider Buying Now at This Insurance Giant and 2 Biotechs - 24/7 Wall St.
Alumis (ALMS) Is Up 22.0% After Phase 3 Psoriasis Win And $300 Million Equity Raise - Yahoo Finance
HC Wainwright & Co. hikes Alumis Inc. (ALMS)’s price target to $40 from $20, reiterates buy rating - MSN
Alumis (ALMS) price target increased by 79.14% to 36.28 - MSN
An Almus (ALMS) Insider Bought 588,000 Shares for $10.0 Million - AOL.com
Staar Surgical, Alumis, and more stocks see action from activist investors - MSN
Staar Surgical, Alumis, and More Stocks See Action From Activist Investors - Barron's
Russell 2000 Kicks Off 2026 Strong, Surging Over 7% Year-to-Date - Intellectia AI
14 Best Booming Stocks to Buy Right Now - Insider Monkey
HC Wainwright & Co. Hikes Alumis Inc. (ALMS)’s Price Target To $40 From $20, Reiterates Buy Rating - Insider Monkey
Alumis (ALMS) Is Up 35.8% After Psoriasis Data And $300M Raise Has The Bull Case Changed? - simplywall.st
HC Wainwright & Co. Hikes Alumis Inc. (ALMS)'s Price Target To $40 From $20, Reiterates Buy Rating - Finviz
Alumis (ALMS) stock jumps as insider filings show $17 buys — what investors are watching next - TechStock²
Why Alumis Inc. Stock Is Surging Right Now - TipRanks
Alumis (NASDAQ:ALMS) Stock Price Up 6.6% Following Insider Buying Activity - MarketBeat
Alumis' Meteoric Rise To $20 From $5 In Just 60 Days On Plaque Psoriasis Trial Results - RTTNews
Alumis (ALMS) Price Target Increased by 79.14% to 36.28 - Nasdaq
Alumis Inc stock hits all-time high at 22.33 USD By Investing.com - Investing.com Nigeria
Assessing Alumis (ALMS) Valuation After Positive Phase 3 Psoriasis Data And Follow On Equity Offering - simplywall.st
Insider Makes Bold Multimillion-Dollar Bet on Alumis Inc. - TipRanks
Insider Buying: Alumis (NASDAQ:ALMS) Director Purchases 588,235 Shares of Stock - MarketBeat
Aug Sectors: Will Alumis Inc stock benefit from automation2025 Performance Recap & Low Drawdown Momentum Trade Ideas - moha.gov.vn
Akkaraju of Alumis buys shares worth $9.9 million By Investing.com - Investing.com Nigeria
Akkaraju of Alumis buys shares worth $9.9 million - Investing.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, Warren Buffett, Balyasny Asset Management, Schonfeld Strategic Advisors, Renaissance Technologies, Anson Investments, Limoneira Co (LMNR), Alumis Inc (ALMS), and More - Insider Monkey
Alumis (NASDAQ:ALMS) Reaches New 1-Year High on Insider Buying Activity - MarketBeat
Alumis Inc stock hits all-time high at 22.33 USD - Investing.com
Why Alumis Inc. Stock Is Quietly Surging Higher - TipRanks
Support Test: Is Alumis Inc stock a buy on dipsMarket Activity Summary & Weekly Top Gainers Alerts - Bộ Nội Vụ
Alumis Inc. Stock (ALMS) Opinions on Phase 3 Trial Results - Quiver Quantitative
Latham & Watkins Advises on Alumis’ Upsized US$345 Million Public Offering of Common Stock - Legal Desire Media and Insights
Insider Buying: Alumis (NASDAQ:ALMS) Major Shareholder Buys 411,764 Shares of Stock - MarketBeat
Alumis Insider Bought Shares Worth $6,999,988, According to a Recent SEC Filing - marketscreener.com
Foresite Labs buys Alumis (ALMS) shares worth $7 million By Investing.com - Investing.com Nigeria
Insider Buying: Alumis (NASDAQ:ALMS) Director Acquires 411,764 Shares of Stock - MarketBeat
Foresite Labs buys Alumis (ALMS) shares worth $7 million - Investing.com
Alumis Inc (ALMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.39%
1.60%
자본화:
|
볼륨(24시간):